PL2488190T3 - Zmniejszanie ryzyka patologicznych skutków urazowego uszkodzenia mózgu - Google Patents
Zmniejszanie ryzyka patologicznych skutków urazowego uszkodzenia mózguInfo
- Publication number
- PL2488190T3 PL2488190T3 PL10824055T PL10824055T PL2488190T3 PL 2488190 T3 PL2488190 T3 PL 2488190T3 PL 10824055 T PL10824055 T PL 10824055T PL 10824055 T PL10824055 T PL 10824055T PL 2488190 T3 PL2488190 T3 PL 2488190T3
- Authority
- PL
- Poland
- Prior art keywords
- risk
- reducing
- brain injury
- traumatic brain
- pathological effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25123009P | 2009-10-13 | 2009-10-13 | |
EP10824055.7A EP2488190B1 (en) | 2009-10-13 | 2010-10-13 | Reducing the risk of pathological effects of traumatic brain injury |
PCT/US2010/052564 WO2011047095A1 (en) | 2009-10-13 | 2010-10-13 | Reducing the risk of pathological effects of traumatic brain injury |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2488190T3 true PL2488190T3 (pl) | 2018-02-28 |
Family
ID=43876523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10824055T PL2488190T3 (pl) | 2009-10-13 | 2010-10-13 | Zmniejszanie ryzyka patologicznych skutków urazowego uszkodzenia mózgu |
Country Status (8)
Country | Link |
---|---|
US (2) | US20110257267A1 (pl) |
EP (1) | EP2488190B1 (pl) |
JP (3) | JP2013507454A (pl) |
AU (1) | AU2010306870B2 (pl) |
CA (1) | CA2777367A1 (pl) |
ES (1) | ES2643628T3 (pl) |
PL (1) | PL2488190T3 (pl) |
WO (1) | WO2011047095A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2488190B1 (en) | 2009-10-13 | 2017-09-20 | DSM IP Assets B.V. | Reducing the risk of pathological effects of traumatic brain injury |
WO2012125020A1 (en) * | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Method for treating neurotrauma |
US9269046B2 (en) | 2012-01-18 | 2016-02-23 | Brainscope Company, Inc. | Method and device for multimodal neurological evaluation |
US8792974B2 (en) * | 2012-01-18 | 2014-07-29 | Brainscope Company, Inc. | Method and device for multimodal neurological evaluation |
EP3579830A4 (en) * | 2017-02-09 | 2021-03-17 | Bodhi Research & Development Inc. | Fatty acid formulations containing cannabis for the treatment of diseases of the nervous system |
AU2018321407A1 (en) * | 2017-08-25 | 2020-03-26 | Struct Nutrition, Llc | Compositions and methods for preventing, alleviating, and treating neurological injury following head trauma |
KR101946362B1 (ko) | 2017-10-27 | 2019-02-11 | 파이코일바이오텍코리아(주) | 뇌 염증성 질환 예방, 개선 또는 치료용 조성물 |
WO2019095280A1 (en) | 2017-11-17 | 2019-05-23 | Shenzhen Qianhai Xiaozao Technology Ltd. | Production of Algae-Derived Polyunsaturated Fatty Acids |
KR20210089647A (ko) * | 2018-11-02 | 2021-07-16 | 마라 리뉴어블즈 코퍼레이션 | 영양가가 개선된 해조 오일 |
AU2020298105A1 (en) | 2019-06-20 | 2022-01-20 | Aker Biomarine Human Ingredients As | Parenteral lysophosphatidylcholine formulations such as LPC-DHA, LPC-EPA and their use in therapy |
NL2023407B1 (en) | 2019-06-28 | 2021-02-01 | Aker Biomarine Antarctic As | Parenteral lysophosphatidylcholine formulations |
WO2022094203A1 (en) * | 2020-10-30 | 2022-05-05 | The Trustees Of The University Of Pennsylvania | Lipid prophylactic brain injury treatment |
FR3132430A1 (fr) * | 2022-02-09 | 2023-08-11 | Polaris | Composition comprenant un melange de dha et/ou d’epa et d’un phospholipide d’orgine vegetale |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
US5506211A (en) * | 1994-05-09 | 1996-04-09 | The Uab Research Foundation | Genistein for use in inhibiting osteroclasts |
US6681403B2 (en) * | 2000-03-13 | 2004-01-27 | Robert M. Lyden | Shin-guard, helmet, and articles of protective equipment including light cure material |
US6469049B1 (en) * | 2000-04-21 | 2002-10-22 | The United States Of America As Represented By The Secretary Of The Army | Method of treating, preventing or inhibiting central nervous system injuries and diseases |
AU2002352726A1 (en) * | 2001-11-15 | 2003-06-10 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
CA2549638A1 (en) * | 2003-12-23 | 2005-07-14 | Pfizer Products Inc. | Therapeutic combination for cognition enhancement and psychotic disorders |
US20050164908A1 (en) | 2004-01-23 | 2005-07-28 | Ginsberg Myron D. | Neuroprotective complex for treatment of cerebral ischemia and injury |
US20060276373A1 (en) | 2004-01-23 | 2006-12-07 | Bazan Nicolas G | Neuroprotective complex for treatment of cerebral ischemia and injury |
US20060059605A1 (en) * | 2004-09-22 | 2006-03-23 | Xenith Athletics, Inc. | Layered construction of protective headgear with one or more compressible layers of thermoplastic elastomer material |
JP5697293B2 (ja) | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
RU2444356C2 (ru) * | 2005-07-08 | 2012-03-10 | Мартек Байосайенсиз Корпорейшн | Полиненасыщенные жирные кислоты для лечения деменции и состояний, связанных с преддеменцией |
US20080038237A1 (en) * | 2006-02-28 | 2008-02-14 | Sapolsky Robert M | Trojan horse immunotherapy |
CN101049297B (zh) | 2006-04-06 | 2010-11-24 | 北京百慧生化制药有限责任公司 | 一种高dha型-乙酯和epa-乙酯的脂肪酸乙酯及其制造方法和制剂 |
US20090023808A1 (en) * | 2007-06-29 | 2009-01-22 | Martek Biosciences Corporation | Production and Purification of Esters of Polyunsaturated Fatty Acids |
WO2009057994A1 (en) * | 2007-11-02 | 2009-05-07 | N.V. Nutricia | Unit dosage for brain health |
EP2488190B1 (en) | 2009-10-13 | 2017-09-20 | DSM IP Assets B.V. | Reducing the risk of pathological effects of traumatic brain injury |
CN109350408B (zh) * | 2018-12-11 | 2024-06-14 | 陶国民 | 过床护理椅 |
-
2010
- 2010-10-13 EP EP10824055.7A patent/EP2488190B1/en active Active
- 2010-10-13 CA CA2777367A patent/CA2777367A1/en not_active Abandoned
- 2010-10-13 WO PCT/US2010/052564 patent/WO2011047095A1/en active Application Filing
- 2010-10-13 AU AU2010306870A patent/AU2010306870B2/en not_active Ceased
- 2010-10-13 ES ES10824055.7T patent/ES2643628T3/es active Active
- 2010-10-13 US US12/904,049 patent/US20110257267A1/en not_active Abandoned
- 2010-10-13 JP JP2012534338A patent/JP2013507454A/ja active Pending
- 2010-10-13 PL PL10824055T patent/PL2488190T3/pl unknown
-
2015
- 2015-11-05 JP JP2015217669A patent/JP6516158B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-11 JP JP2017174229A patent/JP6544747B2/ja not_active Expired - Fee Related
-
2018
- 2018-10-15 US US16/160,388 patent/US11413263B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11413263B2 (en) | 2022-08-16 |
JP6544747B2 (ja) | 2019-07-17 |
JP2018021067A (ja) | 2018-02-08 |
CA2777367A1 (en) | 2011-04-21 |
EP2488190A1 (en) | 2012-08-22 |
AU2010306870A8 (en) | 2012-06-28 |
AU2010306870B2 (en) | 2016-08-18 |
US20110257267A1 (en) | 2011-10-20 |
ES2643628T3 (es) | 2017-11-23 |
JP2013507454A (ja) | 2013-03-04 |
JP2016053065A (ja) | 2016-04-14 |
US20190046495A1 (en) | 2019-02-14 |
WO2011047095A1 (en) | 2011-04-21 |
AU2010306870A1 (en) | 2012-05-03 |
JP6516158B2 (ja) | 2019-05-22 |
EP2488190B1 (en) | 2017-09-20 |
EP2488190A4 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2488190T3 (pl) | Zmniejszanie ryzyka patologicznych skutków urazowego uszkodzenia mózgu | |
HUE040281T2 (hu) | Autoantitest markerek traumás agysérülés diagnózisára | |
IL225731B (en) | Biomarkers for brain injury | |
GB0911580D0 (en) | Use of one or more cannabinoids in the treatment of epilepsy | |
IL253293B (en) | Desferrioxamine complexes of metals for the treatment of diseases related to the immune system | |
EP2501352A4 (en) | WITHDRAWAL OF NON-INVASIVE GREASE | |
IL217901A0 (en) | Treatment of bdnf-related disorders using laquninimod | |
EP2654745A4 (en) | COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN | |
PL2647337T3 (pl) | Urządzenie wywołujące bodźce skóry | |
GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
HK1166472A1 (en) | Treatment of dyskinesia related disorders | |
GB0904285D0 (en) | Compounds for the treatment of metabolic disorders | |
SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
EP2621498A4 (en) | COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS | |
EP2616094A4 (en) | TREATMENT OF BRAIN INJURIES THROUGH IMPORTS | |
ZA201107445B (en) | Compound for the treatment of metabolic disorders | |
IL214133A0 (en) | Skin treatment | |
IL225896A0 (en) | Treatment of mecp-2 related disorders | |
PL2477656T3 (pl) | Leczenie stanów neurologicznych | |
GB0914839D0 (en) | Treatment of oil | |
ZA201204391B (en) | Compounds for the treatment of neurologic disorders | |
ZA201005770B (en) | The treatment of damaged skin | |
GB0814043D0 (en) | The treatment of skin disorders | |
PT2456445E (pt) | Agente para o tratamento de condições da pele |